ASHM Report Back

Clinical posts from members and guests of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) from various international medical and scientific conferences on HIV, AIDS, viral hepatitis, and sexual health.

Subscribe to this list via RSS Blog posts tagged in GS-7340

The renal effects of tenofovir were associated with blood levels (abstract 603) at the conference. Another presentation (abstract 103) examined a prodrug of tenofovir, GS-7340, in a 10 day monotherapy study. This produg was associated with 88% lower plasma levels of tenofovir than when the currently prescribed prodrug TDF (tenofovir disproxil fumarate) was administered. It was highly potent and is likely to be studied further as an alternative to TDF.

Tagged in: CROI2012 GS-7340

RT @SiREN_WA: Abstract submissions are open for the Joint Sexual Health and HIV&AIDS Conferences @ASHMMedia. A number of awards are on offe…

ASHM ASHM

RT @gazamor: OAC08- PrEP at scale: The subsidised PrEP program in Australia has scaled up rapidly since inception. This study identified ch…

ASHM ASHM